drugset / Trial / NCT01937182

The Efficacy of Citalopram Treatment in Acute Stroke

NCT01937182

RandomizedParallel-groupQuadruple-blindTreatment

Summary

We wish to conduct a prospective, randomized, double blind, placebo controlled multi center study of the combined neuroprotective and antithrombotic effects of SSRI treatment after stroke. Hypotheses: SSRI treatment commenced in the acute phase of stroke (day 0-7) protects against new thromboembolic events and leads to better rehabilitation. 600 stroke patients will be randomized in a 1:1 ratio. The treatment and follow up period is 6 months. During these 6 months there will be 2 clinical follow up visits, one telephone control and one visit to evaluate compliance regarding medication.

Timeline

Start
2013-09
Primary completion
2016-12-19
Completion
2016-12-19

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Citalopram Small molecule 10 mg Oral
Comparator Citalopram Small molecule 20 mg Oral

Indications